Impact of hypoglycemic agents on myocardial ischemic preconditioning

doi:10.4239/wjd.v5.i3.258

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 5, Issue 3

This Article

Academic Content and Language Evaluation of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (6114)

All Articles published online

The chart showing PDF series, WORD series, HTML series, Figures (1-1) series, Tables (1-1) series.

Item

Count

PDF

393

WORD

217

HTML

3435

Figures (1-1)

145

Tables (1-1)

202

Sum=4392

Publishing Process of This Article

The chart showing Browse series, Download series.

Item

Count

Browse

823

Download

899

Sum=1722

Jun 15, 2014 (publication date) through Apr 25, 2024

Times Cited of This Article

Times Cited (10)

Journal Information of This Article

Publication Name

World Journal of Diabetes

ISSN

1948-9358

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Topic Highlight

World J Diabetes. Jun 15, 2014; 5(3): 258-266
Published online Jun 15, 2014. doi: 10.4239/wjd.v5.i3.258

Open in New Tab Full Size Figure Download Figure

Figure 1 Diagrammatic representation of the temporal nature of the 2 windows of preconditioning (adapted from Baxter et al[9]). SWOP: Second window of protection.

Citation: Rahmi Garcia RM, Rezende PC, Hueb W. Impact of hypoglycemic agents on myocardial ischemic preconditioning. World J Diabetes 2014; 5(3): 258-266
URL: https://www.wjgnet.com/1948-9358/full/v5/i3/258.htm
DOI: https://dx.doi.org/10.4239/wjd.v5.i3.258